Name | Number of supported studies | Average coverage | |
---|---|---|---|
ciliated cell | 6 studies | 30% ± 8% | |
epithelial cell | 4 studies | 30% ± 8% | |
dendritic cell | 3 studies | 20% ± 3% |
Insufficient scRNA-seq data for expression of PSMD10 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
brain | 100% | 2807.15 | 2642 / 2642 | 100% | 96.31 | 705 / 705 |
esophagus | 100% | 1659.78 | 1445 / 1445 | 100% | 59.92 | 183 / 183 |
ovary | 100% | 1578.21 | 180 / 180 | 100% | 65.67 | 430 / 430 |
intestine | 100% | 1563.99 | 966 / 966 | 100% | 62.53 | 526 / 527 |
uterus | 100% | 1944.08 | 170 / 170 | 100% | 80.61 | 458 / 459 |
breast | 100% | 1654.38 | 459 / 459 | 100% | 81.92 | 1115 / 1118 |
lung | 100% | 1567.71 | 576 / 578 | 100% | 81.94 | 1155 / 1155 |
stomach | 100% | 1197.26 | 359 / 359 | 100% | 59.10 | 285 / 286 |
prostate | 100% | 1445.16 | 245 / 245 | 100% | 56.10 | 500 / 502 |
thymus | 100% | 1519.44 | 653 / 653 | 99% | 62.71 | 601 / 605 |
bladder | 100% | 1701.48 | 21 / 21 | 99% | 68.21 | 500 / 504 |
adrenal gland | 100% | 2178.31 | 258 / 258 | 99% | 89.50 | 228 / 230 |
skin | 100% | 1923.56 | 1808 / 1809 | 99% | 62.11 | 466 / 472 |
kidney | 100% | 1350.55 | 89 / 89 | 99% | 50.45 | 889 / 901 |
liver | 100% | 803.58 | 225 / 226 | 98% | 37.15 | 396 / 406 |
pancreas | 97% | 680.60 | 318 / 328 | 99% | 49.13 | 176 / 178 |
adipose | 100% | 1671.02 | 1204 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 1733.17 | 1335 / 1335 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 100% | 57.96 | 29 / 29 |
spleen | 100% | 1414.41 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 73.80 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 26.30 | 1 / 1 |
muscle | 98% | 738.91 | 788 / 803 | 0% | 0 | 0 / 0 |
heart | 98% | 821.01 | 840 / 861 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 95% | 35.00 | 76 / 80 |
peripheral blood | 68% | 993.42 | 630 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0072659 | Biological process | protein localization to plasma membrane |
GO_0030307 | Biological process | positive regulation of cell growth |
GO_0006357 | Biological process | regulation of transcription by RNA polymerase II |
GO_0032436 | Biological process | positive regulation of proteasomal ubiquitin-dependent protein catabolic process |
GO_0090201 | Biological process | negative regulation of release of cytochrome c from mitochondria |
GO_0045737 | Biological process | positive regulation of cyclin-dependent protein serine/threonine kinase activity |
GO_0000122 | Biological process | negative regulation of transcription by RNA polymerase II |
GO_0032088 | Biological process | negative regulation of NF-kappaB transcription factor activity |
GO_0007253 | Biological process | cytoplasmic sequestering of NF-kappaB |
GO_0043066 | Biological process | negative regulation of apoptotic process |
GO_0043409 | Biological process | negative regulation of MAPK cascade |
GO_0006915 | Biological process | apoptotic process |
GO_0031398 | Biological process | positive regulation of protein ubiquitination |
GO_0070682 | Biological process | proteasome regulatory particle assembly |
GO_0043518 | Biological process | negative regulation of DNA damage response, signal transduction by p53 class mediator |
GO_0000502 | Cellular component | proteasome complex |
GO_0005856 | Cellular component | cytoskeleton |
GO_0005886 | Cellular component | plasma membrane |
GO_0005654 | Cellular component | nucleoplasm |
GO_0043005 | Cellular component | neuron projection |
GO_0045111 | Cellular component | intermediate filament cytoskeleton |
GO_0005829 | Cellular component | cytosol |
GO_0008540 | Cellular component | proteasome regulatory particle, base subcomplex |
GO_0005737 | Cellular component | cytoplasm |
GO_0005634 | Cellular component | nucleus |
GO_0008134 | Molecular function | transcription factor binding |
GO_0061629 | Molecular function | RNA polymerase II-specific DNA-binding transcription factor binding |
GO_0030674 | Molecular function | protein-macromolecule adaptor activity |
GO_0044325 | Molecular function | transmembrane transporter binding |
GO_0008092 | Molecular function | cytoskeletal protein binding |
GO_0005515 | Molecular function | protein binding |
Gene name | PSMD10 |
Protein name | 26S proteasome non-ATPase regulatory subunit 10 (26S proteasome regulatory subunit p28) (Gankyrin) (p28(GANK)) Proteasome 26S subunit, non-ATPase 10 |
Synonyms | |
Description | FUNCTION: Acts as a chaperone during the assembly of the 26S proteasome, specifically of the PA700/19S regulatory complex (RC). In the initial step of the base subcomplex assembly is part of an intermediate PSMD10:PSMC4:PSMC5:PAAF1 module which probably assembles with a PSMD5:PSMC2:PSMC1:PSMD2 module. Independently of the proteasome, regulates EGF-induced AKT activation through inhibition of the RHOA/ROCK/PTEN pathway, leading to prolonged AKT activation. Plays an important role in RAS-induced tumorigenesis.; FUNCTION: Acts as an proto-oncoprotein by being involved in negative regulation of tumor suppressors RB1 and p53/TP53. Overexpression is leading to phosphorylation of RB1 and proteasomal degradation of RB1. Regulates CDK4-mediated phosphorylation of RB1 by competing with CDKN2A for binding with CDK4. Facilitates binding of MDM2 to p53/TP53 and the mono- and polyubiquitination of p53/TP53 by MDM2 suggesting a function in targeting the TP53:MDM2 complex to the 26S proteasome. Involved in p53-independent apoptosis. Involved in regulation of NF-kappa-B by retaining it in the cytoplasm. Binds to the NF-kappa-B component RELA and accelerates its XPO1/CRM1-mediated nuclear export. |
Accessions | ENST00000217958.8 [O75832-1] ENST00000340200.5 B1AJY5 B1AJY6 ENST00000372295.5 O75832 ENST00000372296.5 ENST00000361815.9 [O75832-2] B1AJY7 |